<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2015-45-50</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-2037</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Связь клинических проявлений и коморбидных заболеваний с показателями качества жизни у больных подагрой</article-title><trans-title-group xml:lang="en"><trans-title>ASSOCIATION OF CLINICAL MANIFESTATIONS AND COMORBIDITIES WITH QUALITY-OF-LIFE MEASURES IN PATIENTS WITH GOUT</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елисеев</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Eliseev</surname><given-names>M. S.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мукагова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mukagova</surname><given-names>M. V.</given-names></name></name-alternatives><email xlink:type="simple">maya_mukagova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глухова</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Glukhova</surname><given-names>S. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ Научно- исследовательский институт ревматологии им. В.А. Насоновой, Москва, Россия 115522 Москва, Каширское шоссе, 34А</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia&#13;
34A, Kashirskoe Shosse, Moscow 115522</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>12</day><month>03</month><year>2015</year></pub-date><volume>53</volume><issue>1</issue><fpage>45</fpage><lpage>50</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Елисеев М.С., Мукагова М.В., Глухова С.И., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Елисеев М.С., Мукагова М.В., Глухова С.И.</copyright-holder><copyright-holder xml:lang="en">Eliseev M.S., Mukagova M.V., Glukhova S.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/2037">https://rsp.mediar-press.net/rsp/article/view/2037</self-uri><abstract><p>Цель – выявить факторы, ассоциированные с низким качеством жизни (КЖ) больных подагрой. Материал и методы. В исследование было включено 175 пациентов (153 мужчины и 22 женщины) с достоверным диагнозом подагры. Средний возраст больных составил 48,0±12,3 года, медиана длительности заболевания – 5,7 [3,0; 12,3] года, число приступов артрита за год – 3 [1; 5], средний сывороточный уровень мочевой кислоты (МК) – 510±120 мкмоль/л. 31,4% пациентов принимали аллопуринол, 40,5% имели хронический артрит, 36,5% – подкожные тофусы, 23% – ишемическую болезнь сердца (ИБС), 76% – артериальную гипертензию (АГ), 15,4% – сахарный диабет (СД) 2-го типа, 10,2% – хроническую болезнь почек (ХБП) при скорости клубочковой фильтрации &lt;60 мл/мин, 56% – ожирение, 5,1% – хроническую сердечную недостаточность (ХСН), 9,1% – сосудистые катастрофы в анамнезе. Для выявления корреляционных связей между показателями КЖ по опросникам EQ-5D, SF-36v1, функциональным статусом (ФС) по HAQ и клиническими характеристиками болезни, а также коморбидными заболеваниями проведен корреляционный анализ по Пирсону и Спирмену. Для выделения факторов, ухудшающих КЖ, использовался множественный регрессионный анализ. Результаты и обсуждение. Отрицательные корреляционные связи были обнаружены между показателями КЖ по SF-36 и возрастом, длительностью болезни, сывороточным уровнем МК, наличием хронического артрита, тофусов, приемом аллопуринола, диуретиков, алкоголя, а также АГ, ИБС, ожирением, сосудистыми катастрофами, ХБП и ХСН. После проведения множественного регрессионного анализа была выявлена прямая связь между ухудшением ФС по HAQ и женским полом, пожилым возрастом, числом воспаленных суставов и частотой приступов артрита, коэффициент множественной детерминации (R2) составлял 0,41. КЖ по EQ обратно коррелировало с возрастом, числом воспаленных суставов, частотой приступов артрита, приемом мочегонных препаратов и ожирением (R2=0,33). Снижение физического компонента здоровья опросника SF-36 коррелировало с увеличением возраста, числа воспаленных суставов, частоты приступов артрита и наличием ХБП (R2=0,3), слабая ассоциация отмечалась между ухудшением психологического компонента здоровья и женским полом, увеличением числа воспаленных суставов, сосудистыми катастрофами (R2=0,1). Заключение. Снижение КЖ при подагре независимо ассоциируется с увеличением числа воспаленных суставов, частоты приступов артрита, пожилым возрастом, женским полом и коморбидными заболеваниями (ХБП, ожирением, сосудистыми катастрофами). </p></abstract><trans-abstract xml:lang="en"><p>Objective: to identify factors associated with low quality of life (QL) in patients with gout. Subjects and methods. The investigation enrolled 175 patients (153 men and 22 women) with a definite diagnosis of gout. Their mean age was 48.0±12.3 years; median disease duration – 5.7 [3.0; 12.3] years; the annual number of arthritis attacks – 3 [1; 5]; and the mean serum level of uric acid (UA) – 510±120 μmol/l. 31.4% of the patients received allopurinol; 40.5% had chronic arthritis; 36.5% – subcutaneous tophi, 23% – coronary heart disease (CHD); 76% – hypertension; 15.4% – type 2 diabetes mellitus (DM); 10.2% – chronic kidney disease (CKD) at a glomerular filtration rate of &lt;60 ml/min; 56% – obesity; 5.1% – chronic heart failure (СHF); 9.1% – history of vascular catastrophes. Pearson’s and Spearman’s correlation analyses were made to reveal correlations between QL measures according to the EQ-5D and SF-36v1 questionnaires, HAQ functional status (FS), and the clinical characteristics of the disease, as well as comorbidities. Multiple regression analysis was used to identify factors worsening QL. Results and discussion. Negative correlations were found between SF-36 QL measures and age, disease duration, serum UA level, presence of chronic arthritis and tophi, use of allopurinol, diuretics, alcohol, as well as hypertension, CHD, obesity, vascular catastrophes, CKD, and CHF. The multiple regression analysis established a direct association between HAQ FS worsening and female gender, elderly age, number of inflamed joints and frequency of arthritis attacks; the coefficient of multiple determination (R2) was 0.41. EQ QL correlated inversely with age, number of inflamed joints, frequency of arthritis attacks, intake of diuretics and obesity (R2 = 0.33). The reduction in the SF-36 physical health component correlated with increases in age, number of inflamed joints, and frequency of arthritis attacks, presence of CKD (R2 = 0.3); a weak association was noted between worsening mental health component and female gender, increased number of inflamed joints, and vascular catastrophes (R2 = 0.1). Conclusion. Decreased QL in gout is independently associated with higher number of inflamed joints, frequency of arthritis attacks, elderly age, female gender, and comorbidities (CKD, obesity, vascular catastrophes). </p></trans-abstract><kwd-group xml:lang="ru"><kwd>подагра</kwd><kwd>качество жизни</kwd><kwd>коморбидные заболевания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>gout</kwd><kwd>quality of life</kwd><kwd>comorbidies</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kim KY, Schumacher HR, Hunsche E, et al. A literature review of the epidemiology and treatment of acute gout. Clin Ther. 2003;25(6):1593–617. DOI: 10.1016/S01492918(03)80158-3</mixed-citation><mixed-citation xml:lang="en">Kim KY, Schumacher HR, Hunsche E, et al. A literature review of the epidemiology and treatment of acute gout. Clin Ther. 2003;25(6):1593–617. DOI: 10.1016/S01492918(03)80158-3</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kuo CF, Grainge MJ, Mallen C, et al. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2014 Jan 15. DOI: 10.1136/annrheumdis-2013-204463</mixed-citation><mixed-citation xml:lang="en">Kuo CF, Grainge MJ, Mallen C, et al. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2014 Jan 15. DOI: 10.1136/annrheumdis-2013-204463</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bruce SP, Fugit RV. Breaking the chain of gout: pharmacist strategies to improve patient outcomes in gout and hyperuricemia. A case-based monograph focusing on gout and hyperuricemia for pharmacists. A continuing pharmacy education activity. U.S. Pharmacist. 2010 Feb;(2):1–12.</mixed-citation><mixed-citation xml:lang="en">Bruce SP, Fugit RV. Breaking the chain of gout: pharmacist strategies to improve patient outcomes in gout and hyperuricemia. A case-based monograph focusing on gout and hyperuricemia for pharmacists. A continuing pharmacy education activity. U.S. Pharmacist. 2010 Feb;(2):1–12.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Edwards NL, Sunday JS. Forsuthe A, et al. Work productivity loss due to flares in patient with chronic gout refractory to conventional therapy. J Med Econ. 2011;14(1):10–5. DOI: 10.3111/13696998.2010.540874</mixed-citation><mixed-citation xml:lang="en">Edwards NL, Sunday JS. Forsuthe A, et al. Work productivity loss due to flares in patient with chronic gout refractory to conventional therapy. J Med Econ. 2011;14(1):10–5. DOI: 10.3111/13696998.2010.540874</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Мукагова МВ, Барскова ВГ, Елисеев МС. Особенности качества жизни больных подагрой. Доктор.Ру. Кардиология Ревматология. 2014;(4):54–7 [Mukagova MV, Barskova VG, Eliseev MS. Especially the quality of life of patients with gout. Doktor.Ru. Kardiologiya Revmatologiya. 2014;(4):54–7 (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Мукагова МВ, Барскова ВГ, Елисеев МС. Особенности качества жизни больных подагрой. Доктор.Ру. Кардиология Ревматология. 2014;(4):54–7 [Mukagova MV, Barskova VG, Eliseev MS. Especially the quality of life of patients with gout. Doktor.Ru. Kardiologiya Revmatologiya. 2014;(4):54–7 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chandratre P, Roddy E, Clarson L, et al. Health-related quality of life in gout: a systematic review. Rheumatology. 2013;52(11):2031–40. DOI: 10.1093/rheumatology/ket265</mixed-citation><mixed-citation xml:lang="en">Chandratre P, Roddy E, Clarson L, et al. Health-related quality of life in gout: a systematic review. Rheumatology. 2013;52(11):2031–40. DOI: 10.1093/rheumatology/ket265</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lee SJ, Hirsch JD, Terkeltaub R, et al. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009;48(5):582–6. DOI: 10.1093/rheumatology/kep047</mixed-citation><mixed-citation xml:lang="en">Lee SJ, Hirsch JD, Terkeltaub R, et al. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009;48(5):582–6. DOI: 10.1093/rheumatology/kep047</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna D, Ahmed M, Yontz D, et al. The disutility of chronic gout. Qual Life Res. 2008;17:815–22. DOI: 10.1007/s11136-0089355-0</mixed-citation><mixed-citation xml:lang="en">Khanna D, Ahmed M, Yontz D, et al. The disutility of chronic gout. Qual Life Res. 2008;17:815–22. DOI: 10.1007/s11136-0089355-0</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Мукагова МВ, Барскова ВГ, Елисеев МС. Качество жизни больных подагрой мужчин: есть ли отличия от популяции? Результаты сравнительного исследования. Научнопрактическая ревматология. 2014;52(3):300–3. [Mukagova MV, Barskova VG, Eliseev MS. Quality of life of male gouty patients: are there differences from the population? Results of a comparative study. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(3):300–3 (In Russ.)]. DOI: 10.14412/1995-4484-2014-300-303</mixed-citation><mixed-citation xml:lang="en">Мукагова МВ, Барскова ВГ, Елисеев МС. Качество жизни больных подагрой мужчин: есть ли отличия от популяции? Результаты сравнительного исследования. Научнопрактическая ревматология. 2014;52(3):300–3. [Mukagova MV, Barskova VG, Eliseev MS. Quality of life of male gouty patients: are there differences from the population? Results of a comparative study. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(3):300–3 (In Russ.)]. DOI: 10.14412/1995-4484-2014-300-303</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford). 2007;46(9):1441–4. DOI: 10.1093/rheumatology/kem150</mixed-citation><mixed-citation xml:lang="en">Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford). 2007;46(9):1441–4. DOI: 10.1093/rheumatology/kem150</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Барскова ВГ, Елисеев МС, Денисов ИС и др. Частота метаболического синдрома и сопутствующих заболеваний у больных подагрой. Даннные многоцентрового исследования. Научно-практическая ревматология. 2012;50(6):15–8 [Barskova VG, EliseyevMS, Denisov IS, et al. The rate of metabolic syndrome and comorbiditiesin patients with gout: data of a multicenter trial. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2012;50(6):15–8 (In Russ.)]. DOI: 10.14412/1995-4484-20121287</mixed-citation><mixed-citation xml:lang="en">Барскова ВГ, Елисеев МС, Денисов ИС и др. Частота метаболического синдрома и сопутствующих заболеваний у больных подагрой. Даннные многоцентрового исследования. Научно-практическая ревматология. 2012;50(6):15–8 [Barskova VG, EliseyevMS, Denisov IS, et al. The rate of metabolic syndrome and comorbiditiesin patients with gout: data of a multicenter trial. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2012;50(6):15–8 (In Russ.)]. DOI: 10.14412/1995-4484-20121287</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Reidel AA, Nelson M, Joseph-Ridge N, et al. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol. 2004;31(8):1575–81.</mixed-citation><mixed-citation xml:lang="en">Reidel AA, Nelson M, Joseph-Ridge N, et al. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol. 2004;31(8):1575–81.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Strand V, Edwards L, Singh JA. Health-related quality of life (HRQOL) of patients with treatment failure gout is poor, and comparable to that in other severe chronic conditions. Ann Rheum Dis. 2009;68(3):168.</mixed-citation><mixed-citation xml:lang="en">Strand V, Edwards L, Singh JA. Health-related quality of life (HRQOL) of patients with treatment failure gout is poor, and comparable to that in other severe chronic conditions. Ann Rheum Dis. 2009;68(3):168.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Radner H, Smolen JS, Aletaha D. Remission in rheumatoid arthritis: benefit over low disease activity in patient reported outcomes and costs. Arthritis Res Ther. 2014;16(1):56. DOI: 10.1186/ar4491</mixed-citation><mixed-citation xml:lang="en">Radner H, Smolen JS, Aletaha D. Remission in rheumatoid arthritis: benefit over low disease activity in patient reported outcomes and costs. Arthritis Res Ther. 2014;16(1):56. DOI: 10.1186/ar4491</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Singh JA, Borowsky SJ, Nugent S, et al. Health-related quality of life, functional impairment, and healthcare utilization by veterans: veterans' quality of life study. J Am Geriatr Soc. 2005 Jan;53(1):108–13. DOI: 10.1111/j.1532-5415.2005.53020.x</mixed-citation><mixed-citation xml:lang="en">Singh JA, Borowsky SJ, Nugent S, et al. Health-related quality of life, functional impairment, and healthcare utilization by veterans: veterans' quality of life study. J Am Geriatr Soc. 2005 Jan;53(1):108–13. DOI: 10.1111/j.1532-5415.2005.53020.x</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Abu-Shakra M, Mader R, Langevitz P, et al. Quality of life in systemic lupus erythematosus: A controlled study. J Rheumatol. 1999;26:306–9.</mixed-citation><mixed-citation xml:lang="en">Abu-Shakra M, Mader R, Langevitz P, et al. Quality of life in systemic lupus erythematosus: A controlled study. J Rheumatol. 1999;26:306–9.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna PP, Nuki G, Bardin T, et al. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a crosssectional survey. Health Qual Life Outcom. 2012;10:117. DOI: 10.1186/1477-7525-10-117</mixed-citation><mixed-citation xml:lang="en">Khanna PP, Nuki G, Bardin T, et al. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a crosssectional survey. Health Qual Life Outcom. 2012;10:117. DOI: 10.1186/1477-7525-10-117</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008;67:1310–6. DOI: 10.1136/ard.2007.081604</mixed-citation><mixed-citation xml:lang="en">Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008;67:1310–6. DOI: 10.1136/ard.2007.081604</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor WJ, Colvine K, Gregory K, et al. The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout. Clin Exp Rheumatol. 2008;26(4):620–6.</mixed-citation><mixed-citation xml:lang="en">Taylor WJ, Colvine K, Gregory K, et al. The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout. Clin Exp Rheumatol. 2008;26(4):620–6.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna PP, Perez-Ruiz F, Maranian P, Khanna D. Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form36 is responsive to change in chronic gout. Rheumatology (Oxford). 2011;50(4):740–5. DOI: 10.1093/rheumatology/keq346</mixed-citation><mixed-citation xml:lang="en">Khanna PP, Perez-Ruiz F, Maranian P, Khanna D. Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form36 is responsive to change in chronic gout. Rheumatology (Oxford). 2011;50(4):740–5. DOI: 10.1093/rheumatology/keq346</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bharmal M, Thomas J 3rd. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health. 2006;9(4):262–71. DOI: 10.1111/j.1524-4733.2006.00108.x</mixed-citation><mixed-citation xml:lang="en">Bharmal M, Thomas J 3rd. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health. 2006;9(4):262–71. DOI: 10.1111/j.1524-4733.2006.00108.x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Becker MA, Schumacher HR, Benjamin KL, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol. 2009 May; 36(5):1041–8. DOI: 10.3899/jrheum.071229</mixed-citation><mixed-citation xml:lang="en">Becker MA, Schumacher HR, Benjamin KL, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol. 2009 May; 36(5):1041–8. DOI: 10.3899/jrheum.071229</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Scire CA, Carrara G, Manara M, et al. Сlinical predictors of functional disability in patients with gout: analysis from a multicentre observational study of the italian society for rheumatology. Ann Rheum Dis. 2014;73(Suppl 2):2 774. DOI: 10.1136/annrheumdis2014-eular.1775</mixed-citation><mixed-citation xml:lang="en">Scire CA, Carrara G, Manara M, et al. Сlinical predictors of functional disability in patients with gout: analysis from a multicentre observational study of the italian society for rheumatology. Ann Rheum Dis. 2014;73(Suppl 2):2 774. DOI: 10.1136/annrheumdis2014-eular.1775</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Scire CA, Manara M, Cimmino MA, et al. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013;15(5):101. DOI: 10.1186/ar4281</mixed-citation><mixed-citation xml:lang="en">Scire CA, Manara M, Cimmino MA, et al. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013;15(5):101. DOI: 10.1186/ar4281</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lee SJ, Hirsch JD, Terkeltaub R, et al. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009;48(5):582–6. DOI: 10.1093/rheumatology/kep047</mixed-citation><mixed-citation xml:lang="en">Lee SJ, Hirsch JD, Terkeltaub R, et al. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009;48(5):582–6. DOI: 10.1093/rheumatology/kep047</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Елисеев МС, Чикаленкова НА, Барскова ВГ. Клинические особенности подагры у женщин: результаты сравнительного исследования. Научно-практическая ревматология. 2014;52(2):178–82. [Eliseev MS, Chikalenkova NA, Barskova VG. Clinical features of gout in women: the results of a comparative tudy. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(2):178–82 (In Russ.)]. DOI: 10.14412/1995-44842014-178-182</mixed-citation><mixed-citation xml:lang="en">Елисеев МС, Чикаленкова НА, Барскова ВГ. Клинические особенности подагры у женщин: результаты сравнительного исследования. Научно-практическая ревматология. 2014;52(2):178–82. [Eliseev MS, Chikalenkova NA, Barskova VG. Clinical features of gout in women: the results of a comparative tudy. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(2):178–82 (In Russ.)]. DOI: 10.14412/1995-44842014-178-182</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Singh JA. The impact of gout on patient's lives: a study of AfricanAmerican and Caucasian men and women with gout. Arthritis Res Ther. 2014;16(3):132. DOI: 10.1186/ar4589.</mixed-citation><mixed-citation xml:lang="en">Singh JA. The impact of gout on patient's lives: a study of AfricanAmerican and Caucasian men and women with gout. Arthritis Res Ther. 2014;16(3):132. DOI: 10.1186/ar4589.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
